Article Details

Zacks Investment Research Downgrades Allena Pharmaceuticals (NASDAQ:ALNA) to Sell

Retrieved on: 2021-03-12 21:22:30

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Downgrades Allena Pharmaceuticals (NASDAQ:ALNA) to Sell. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 164,056 shares of the company's stock valued at $210,000 after acquiring an additional 28,858 shares during the period.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up